Dr Amitava Banerjee

Dr Amitava BanerjeeTel: 020 3447 5540
Fax: 020 3447 9278
Email: amitava.banerjee@nhs.net

Location:
University College Hospital

Specialities:
Heart failure service, Cardiac services

Professional background

After qualifying from Oxford, Dr Ami Banerjee trained as a junior doctor in Oxford, Newcastle, Hull and London. His interest in preventive cardiology and evidence-based medicine led to a Masters in Public Health at Harvard(2004/05), an internship at the World Health Organisation(2005) and DPhil in epidemiology from Oxford(2010). He was Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham, before taking up the position of Senior Lecturer in Clinical Data Science and Honorary Consultant in Cardiology at the Farr Institute of Health Informatics in August 2015. In addition to general cardiology, he has special interest in heart failure and atrial fibrillation, and also the role of informatics and electronic health records in delivering better patient care.

Research interests

  • Prevention of cardiovascular disease
  • Epidemiology of heart failure, atrial fibrillation and other cardiovascular diseases
  • Health informatics
  • Global cardiovascular burden

Publications

Selected publications

Howard DP, Banerjee A, Fairhead JF, Hands L, Silver LE, Rothwell PM; Oxford Vascular Study. A Population-Based Study of Incidence, Risk Factors, Outcome and Prognosis of Ischaemic Peripheral Arterial Events: Implications for Prevention. Circulation. 2015 Sep 8.

Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM; Oxford Vascular Study. Population-Based Study of Incidence of Acute Abdominal Aortic Aneurysms With Projected Impact of Screening Strategy. J Am Heart Assoc. 2015 Aug 19;4(8).

Menon J, Vijayakumar N, Joseph JK, David PC, Menon MN, Mukundan S, Dorphy PD, Banerjee A. Below the poverty line and non-communicable diseases in Kerala: The Epidemiology of Non-communicable Diseases in Rural Areas (ENDIRA) study. Int J Cardiol. 2015;187:519-524

GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-71.

Banerjee A. Poverty, development and cardiovascular trials: More questions than answers? Heart. 2014 Epub Dec 23.
 
Banerjee A, Clementy N, Haguenoer K, Fauchier L, Lip GY. Prior history of falls and risk of outcomes in atrial fibrillation: the loire valley atrial fibrillation project. Am J Med. 2014;127:972-8.

Banerjee A, Clementy N, Haguenoer K, Fauchier L, Lip GY. Prior history of falls and risk of outcomes in atrial fibrillation: the loire valley atrial fibrillation project. Am J Med. 2014;127:972-8 
  
Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol. 2013;61:2079-87.
 
Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM; Oxford Vascular Study. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127:2031-7.

Banerjee A, Lim CC, Silver LE, Heneghan C, Welch SJ, Mehta Z, Banning AP, Rothwell PM. Family history does not predict angiographic localization or severity of coronary artery disease. Atherosclerosis. 2012;221: 451-7.

Banerjee A, Hollis A and Pogge T. The Health Impact Fund: incentives for improving access to medicines. Lancet 2010. 375:166-169.

GMC/GDC number: 6055470